Carregant...
Quantitative ubiquitylome analysis and crosstalk with proteome/acetylome analysis identified novel pathways and targets of perifosine treatment in neuroblastoma
BACKGROUND: Perifosine, is a third generation alkylphospholipid analog which has promising anti-tumor efficacy in clinical trials of refractory/recurrent neuroblastoma (NB). However, perifosine’s mechanism of action remains unclear. Previously, we have shown that perifosine changes global proteome a...
Guardat en:
| Publicat a: | Transl Cancer Res |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6370305/ https://ncbi.nlm.nih.gov/pubmed/30761266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tcr.2018.11.30 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|